Mgr. Renata Chloupková
Analyst, Institute of Biostatistics and Analyses
correspondence Address:
Kamenice 753/5, 625 00 Brno
e‑mail: |
---|
Total number of publications: 87
2017
-
Léčba pokročilého nemalobuněčného karcinomu plic (NSCLC) v ČR v roce 2017 (aktuální stav, výhled do budoucna)
Year: 2017, type: Conference abstract
-
Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer
CLINICAL GENITOURINARY CANCER, year: 2017, volume: 15, edition: 6, DOI
-
Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed
Neoplasma, year: 2017, volume: 64, edition: 4, DOI
-
Registr TULUNG
Year: 2017, type: Conference abstract
-
Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry
Targeted Oncology, year: 2017, volume: 12, edition: 1, DOI
-
Sledování nákladné pneumoonkologické léčby pokročilého nemalobuněčného karcinomu plic v první linii v registru TULUNG v České republice (stav k 15.3.2017)
Year: 2017, type: Popularization text
-
Stav léčby pokročilého nemalobuněčného karcinomu plic (NSCLC) v ČR v roce 2017
Year: 2017, type: Conference abstract
-
Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous non-small cell lung cancer treated with pemetrexed-based chemotherapy
Tumor Biology, year: 2017, volume: 39, edition: 2, DOI
-
Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry
BMC Cancer, year: 2017, volume: 17, edition: 880, DOI